From the blog

Rescale Partners with Google Cloud and Microsoft Azure to Accelerate the Race for COVID-19 Vaccine with Cloud Supercomputers for Researchers

High performance computing resources immediately available at no cost to engineers, scientists, and researchers fighting the novel coronavirus 

SAN FRANCISCO, March 19, 2020 — Rescale Inc., the leader in enterprise big compute, in cooperation with Google Cloud and Microsoft Azure, announced a new program today that immediately offers high performance computing resources (HPC) at no cost to teams working to develop test kits and vaccines for COVID-19.

Those working on coronavirus vaccines and testing who would benefit from HPC in the cloud at no cost should contact support@techagainstcovid.com. Researchers can rapidly run simulations in the cloud without setup time or IT teams using Rescale’s turnkey platform combined with cloud computing resources from Google Cloud Platform and Microsoft Azure. 

For decades, bioscience and pharmaceutical companies have been using high performance computing to develop and validate new solutions and drugs. With this technology now available via the cloud at no cost, researchers from around the globe can speed up COVID-19 vaccine discovery by ramping up and collaborating from anywhere. 

“Rescale’s platform can provide access to high-performance computing resources that can help accelerate key processes and enable stronger collaboration,” said Manvinder Singh, Director, Partnerships at Google Cloud. “As a partner of Rescale, we’re grateful that they will make these resources, including Google Cloud computing capabilities, available to more researchers and organizations.”

Greg Moore, Corporate Vice President, Microsoft Health added, “We’re inspired to team up with Rescale in the fight against time to help provide answers to address COVID-19. To enable researchers and organizations to develop new therapeutics and vaccines faster, we’re working together to accelerate the availability of Azure supercomputers in the cloud.”

“As a leading life sciences company, we believe it is our duty to step up and help to stop this deadly and devastating pandemic,” said Erik Holmlin, PhD, CEO of Bionano Genomics.  “Bionano’s genome imaging technology can identify variation in genome structure better than any sequencing-based method, which makes us uniquely positioned to help identify variants in the human genome that can protect against or predispose to the viral infection. We have set up studies to identify such variants around the globe, and having Bionano’s bioinformatic tools already integrated onto Rescale’s high performance computing platform enables us to scale up these studies rapidly across multiple continents.” 

With the introduction of cloud HPC, Rescale, a Microsoft M12 portfolio company, makes massive workloads solvable in a scalable, customized time frame.  By eliminating the need to maintain an on-premises supercomputer, cloud HPC allows startups and enterprises alike to develop new drugs and vaccines faster than ever.  

“Leading cloud companies need to pitch in, and we have the responsibility to help in any way we can,” said Joris Poort, CEO of Rescale.  “Rescale is making every effort working closely with our cloud provider partners to eliminate bottlenecks and costs so researchers achieve breakthroughs faster.”

“We will work around the clock to make these findings available to the scientific and public health communities,” said Holmlin, “and hope that we can contribute to vaccine or drug development, better triage and treatment of patients, and overall management of the disease and epidemic.”

To learn more about how to leverage these new resources to fight COVID-19, visit www.techagainstcovid.com.

 

About Rescale: 

Rescale is the leader in enterprise big compute in the cloud. Rescale empowers the world’s transformative executives, IT leaders, engineers, and scientists to securely manage product innovation to be first to market. Rescale’s ScaleX® multi-cloud platform, built on the most powerful high-performance computing infrastructure, seamlessly matches software applications with the best cloud or on-premise architecture to run complex data processing and simulations. For more information on Rescale, visit www.rescale.com.

Contact:

Jolie Hales

Rescale, Inc.

jolie@rescale.com

 

Related articles

Industry Perspective With SpaceX Lead Software Engineer Stephen Jones

Stephen Jones is a lead software engineer at SpaceX and former CUDA architect at NVIDIA For this post, Stephen Jones gives his perspective on aspects of technology of great interest to Rescale’s users. As a major contributor to CUDA, many […]

read more »

複数ジョブ実行時の時間と経費を節約する新機能:Persistent Clusters (永続クラスター)

RescaleのRahul Vergheseが、2017年1月19日に記載したBlog記事の翻訳です。 元記事はIntroducing Persistent Clusters: a New Feature to Save Time & Money with Multiple Jobsをご覧ください。 Rescaleは、最新のデプロイメントで新機能のPersistent Clusters (以下、「永続クラスター」:マニュアルで起動/削除可能なクラスター)をリリースしました。この機能を有効にすることで、複数のインスタンスを起動してクラスタを構築し、シャットダウン(訳注:Rescaleシステムではシャットダウン後インスタンスは削除されます)することなく、Rescaleワークフロー(Web UI)を使用して複数のジョブを順番に同じクラスターへ投入できます。以前は、各ジョブ毎にクラスターが稼働し、ジョブの完了後は自動的にシャットダウンされるため、複数の小さなジョブを実行すると遅延が発生する可能性がありました。この新しい機能により、繰り返し処理の高速化が可能になります。これは、テストや同じハードウェア構成を必要とする複数のジョブに特に便利です。 時間とお金を節約 一般に、各クラスターがスピンアップしてシャットダウンするまでには数分かかります。永続的クラスターを有効にしておくと、クラスターに追加する各ジョブの時間とコストを節約できます。 なぜ? 標準のクラスターは、ジョブが完了すると自動的にシャットダウンし、後続のジョブも同じように起動してシャットダウンするため、別々のクラスターとしてそれぞれ課金されます。(訳注:通常、たとえ10分の計算であっても1時間分の課金となるため、10分で完了する連続する2つのジョブを実行した場合、2時間分が課金されます)一方で、永続クラスターを使用すると、クラスターはすぐに次のジョブの実行に使用できるようになるため、ジョブ間で別のクラスターをシャットダウンして起動させる時間を無駄にしません。それによって、同様のジョブを多数立ち上げるユーザーにとって、時間とコストを大幅に節約することになります。(訳注:上記の例だとちょうど10分の計算を待ち時間なく2つ連続的に実施できることになり、1時間分の課金で収まることになります。)

read more »

Leave a Reply

Your email address will not be published. Required fields are marked *